OptimizeRx CorporationOPRXNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank57
Studio
Year-over-Year Change

Research and development spending

Latest
$171000.00
↓ 56% vs avg
Percentile
P57
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$385827.30
Historical baseline
PeriodValueYoY Change
TTM$171000.00-
2024$0.00-
2023$0.00-
2022$0.00-
2021$0.00-
2020$0.00-100.0%
2019$1.60M+137.4%
2018$675660.00-33.0%
2017$1.01M+153.3%
2016$398396.00-